NEXICLON
Live / Registered — Registered (as of 01 Nov 2022)
What this means for you
Registered since 01 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88672961
- Registration number
- 6890002
- Mark type
- Stylized text
- Filed
- 29 Oct 2019
- Published for opposition
- 10 Mar 2020
- Registered
- 01 Nov 2022
- Attorney of record
- Cathy A. Kodroff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism
Owner
- TRIS PHARMA, INC, Monmouth Junction, NJ, US
- TRIS PHARMA, INC, Monmouth Junction, NJ, US
- TRIS PHARMA, INC, Monmouth Junction, NJ, US
Prosecution history
- 01 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Sept 2022 — USE AMENDMENT FILED
- 29 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 29 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2022 — SOU EXTENSION 4 GRANTED
- 27 Apr 2022 — SOU EXTENSION 4 FILED
- 27 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Jan 2022 — ASSIGNED TO EXAMINER
- 06 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2021 — SOU EXTENSION 3 GRANTED